What Each Compound Does Retatrutide (LY3437943) is a triple agonist: GLP-1 (cuts appetite, slows the stomach), GIP (improves insulin signaling), and glucagon (raises energy use and fat burning)
This data-driven approach transforms 'trial and error' into 'precision medicine.' How Your Genetics Relate to GLP-1 Pathways Not everyone responds to GLP-1 medications the same way
Inactive ingredient ratings Nutrients BPC-157 500mcg Tetrahydrocurcumin 200mg Suggested use: Take 1 capsule up to 2 times per day with food
Glutathione deficiency is involved in chronic diseases, including Alzheimer's disease, Parkinson's disease, liver disease, cancer, heart disease, and diabetes
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 398(10317):21602172